Precision Medicine acquires Project Farma

By The Science Advisory Board staff writers

January 15, 2021 -- Precision Medicine has acquired Project Farma, a bioengineering services firm.

Project Farma has led more than a dozen manufacturing facility builds with capital investments greater than $1 billion. The company has been involved in the development of several cell and gene therapy medicines.

The firm will be part of Precision for Medicine, Precision Medicine's research and development services arm.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.